ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Rob Vries on organoids for drug discovery and the study of COVID-19"
Episode Synopsis
BioTechniques Digital Editor, Tristan Free, speaks to Rob Vries, CEO of Hubrecht Organoid Technology otherwise known as the HUB. We explore the HUB's use of organoids for drug development and further study and improve the clinical treatments of diseases such as cystic fibrosis. After an analysis of the advantages of organoids over 2D cell cultures and animal models, we dive into how HUB's organoids are being used to investigate COVID-19*The Talking Techniques podcast is hosted and produced by Tristan Free for BioTechniques. We would love to here more from our listeners about your opinions on the podcast, what you would like to hear more of and what you think we could do better!Please get in contact on any of the platforms below.Twitter: @TristanFreefsgEmail: [email protected] Hosted on Acast. See acast.com/privacy for more information.
More episodes of the podcast Talking Techniques
Cytokine networks in autoimmune diseases: mechanisms, pathogenesis and therapeutic innovations
19/06/2025
Cytokines: from therapeutics to diagnostics
10/07/2024
Rare disease and pharmacogenomics
23/01/2024
One man’s waste in another man’s treasure: using wastewater to monitor infectious diseases
18/12/2023
Next-generation antibody therapeutics
22/11/2023
In God we trust